Antibodies and CD4+ T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain

被引:28
作者
Droebner, Karoline
Haasbach, Emanuel
Fuchs, Cordula [2 ]
Weinzierl, Andreas O. [3 ]
Stevanovic, Stefan [3 ]
Buettner, Mathias [2 ]
Planz, Oliver [1 ]
机构
[1] Friedrich Loeffler Inst, Inst Immunol, Fed Res Inst Anim Hlth, D-72076 Tubingen, Germany
[2] Bavarian Hlth & Food Safety Author, D-85764 Oberschleissheim, Germany
[3] Interfac Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany
关键词
Cross-protection; H5N1 influenza virus; Vaccine strategy;
D O I
10.1016/j.vaccine.2008.09.051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A H5N2 low pathogenic avian influenza virus (LPAIV) was isolated from a natural reservoir in Bavaria during a routine screen and was Used as a vaccine strain to Scrutinize the immune response involved in cross-protection after challenge infection with a H5N1highly pathogenic avian influenza Virus (HPAIV). The challenge virus was also isolated from a natural reservoir in Bavaria. Wild type, antibody deficient (mu MT), CD4(-/-) and CD8(-/-) mice were infected with the apathogenic H5N2 vaccine strain and challenge infection with a 100-fold MLD50 of the H5N1 strain was performed 80 days later. While 100% of the wild type and 100% of the CD8(-/-) mice stayed healthy, only 50% of the CD4(-/-) and none of the antibody deficient mice were protected. These results Support the view that the humoral immune response and to certain extends the CD4(+) T helper cells are a prerequisite for cross-protective immunity against H5 influenza virus. (C) 2008 Elsevier Ltd. All rights reserved,
引用
收藏
页码:6965 / 6974
页数:10
相关论文
共 44 条
[1]   T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction? [J].
Bachmann, MF ;
Hengartner, H ;
Zinkernagel, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) :3445-3451
[2]   Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system [J].
Brett, IC ;
Johansson, BE .
VIROLOGY, 2005, 339 (02) :273-280
[3]   Influenza vaccine: The challenge of antigenic drift [J].
Carrat, F. ;
Flahault, A. .
VACCINE, 2007, 25 (39-40) :6852-6862
[4]   Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines [J].
Cox, RJ ;
Brokstad, KA ;
Ogra, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 59 (01) :1-15
[5]   Universal influenza A vaccine: Optimization of M2-based constructs [J].
De Filette, M ;
Jou, WM ;
Birkett, A ;
Lyons, K ;
Schultz, B ;
Tonkyro, A ;
Resch, S ;
Fiers, W .
VIROLOGY, 2005, 337 (01) :149-161
[6]   Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA [J].
Diebold, SS ;
Kaisho, T ;
Hemmi, H ;
Akira, S ;
Sousa, CRE .
SCIENCE, 2004, 303 (5663) :1529-1531
[7]   Effector CD4(+) and CD8(+) T-cell mechanisms in the control of respiratory virus infections [J].
Doherty, PC ;
Topham, DJ ;
Tripp, RA ;
Cardin, RD ;
Brooks, JW ;
Stevenson, PG .
IMMUNOLOGICAL REVIEWS, 1997, 159 :105-117
[8]   A "universal" human influenza A vaccine [J].
Fiers, W ;
De Filette, M ;
Birkett, A ;
Neirynck, S ;
Jou, WM .
VIRUS RESEARCH, 2004, 103 (1-2) :173-176
[9]  
Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171
[10]   THE B-CELL RESPONSE IN LYMPHOID-TISSUE OF MICE IMMUNIZED WITH VARIOUS ANTIGENIC FORMS OF THE INFLUENZA-VIRUS HEMAGGLUTININ [J].
JUSTEWICZ, DM ;
DOHERTY, PC ;
WEBSTER, RG .
JOURNAL OF VIROLOGY, 1995, 69 (09) :5414-5421